ID
11871
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (3)
- 8/13/15 8/13/15 - Martin Dugas
- 5/24/16 5/24/16 -
- 5/28/16 5/28/16 -
Uploaded on
August 13, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant Medication Multiple Sclerosis ALAIN01 NCT02419378
Concomitant Medication Multiple Sclerosis ALAIN01 NCT02419378
Description
Concomitant Medication RQG
Alias
- UMLS CUI-1
- C2347852
Description
Concomitant Medication: Generic Name/Trade Name
Data type
text
Alias
- UMLS CUI [1]
- C2347852
Description
Concomitant Medication: Indication
Data type
text
Alias
- UMLS CUI [1]
- C2826696
Description
Concomitant Medication: Dose Morning
Data type
text
Alias
- UMLS CUI [1,1]
- C2826811
Description
Concomitant Medication: Dose Noon
Data type
text
Alias
- UMLS CUI [1]
- C2826811
Description
Concomitant Medication: Dose Evening
Data type
text
Alias
- UMLS CUI [1]
- C2826811
Description
Concomitant Medication: Dose Bed
Data type
text
Alias
- UMLS CUI [1]
- C2826811
Description
Concomitant Medication: Start Date
Data type
date
Alias
- UMLS CUI [1]
- C2826734
Description
Concomitant Medication: Start Date Status
Data type
text
Description
Concomitant Medication: End Date
Data type
date
Alias
- UMLS CUI [1]
- C2826744
Description
Concomitant Medication: End Date Status
Data type
text
Description
Concomitant Medication: ongoing
Data type
text
Alias
- UMLS CUI [1]
- C2826666